Other
Metabolic Disorders
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Metabolic Disorders is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Terminated1 · 33%
Not yet recruiting1 · 33%
Recruiting1 · 33%
Clinical Trials
Trial Activity
Hepatocyte Transplantation for Liver Based Metabolic Disorders
Terminated·—·Phase 1·NCT01345578·5 enrolled
Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders
Not yet recruiting·—·N/A·NCT06358118·240 enrolled
A Natural History Study of Metabolic Sizing in Health and Disease
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·N/A·NCT05398783·2,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)